HF Advisory Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1963169 Annapolis, MD

Position in LLY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,693,920

+$883,813 QoQ

Shares Held

2,246

+14.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

#2,226

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HF Advisory Group, LLC holds $13,388,647 across 8 Drug Manufacturers - General names. LLY ranks #2 (20.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	23,463	$2,964,315
2	LLY	ELI LILLY & Co This page	2,246	$2,693,920
3	PFE	Pfizer Inc	102,378	$2,465,262
4	SNY	Sanofi	37,289	$1,590,748
5	NVS	Novartis AG	8,551	$1,340,112
6	JNJ	Johnson & Johnson	4,322	$1,097,658
7	AMGN	Amgen Inc	2,318	$839,394
8	GSK	GSK plc	7,578	$397,238

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,693,920	2,246	+14.1%	Shares	Sole	2026-07-09
2026-03-31	$1,810,107	1,968	-2.8%	Shares	Sole	2026-04-21
2025-12-31	$2,176,227	2,025	-8.9%	Shares	Sole	2026-01-23
2025-09-30	$1,696,149	2,223	+35.8%	Shares	Sole	2025-10-06
2025-06-30	$1,276,090	1,637	+13.3%	Shares	Sole	2025-07-10
2025-03-31	$1,193,439	1,445	+18.3%	Shares	Sole	2025-04-10
2024-12-31	$942,612	1,221	-47.1%	Shares	Sole	2025-01-15
2024-09-30	$2,045,635	2,309	-2.0%	Shares	Sole	2024-10-30
2024-06-30	$2,133,980	2,357	-7.9%	Shares	Sole	2024-07-18
2024-03-31	$1,990,799	2,559	-1.6%	Shares	Sole	2024-04-22
2023-12-31	$1,515,592	2,600	-17.8%	Shares	Sole	2024-01-31
2023-09-30	$1,698,942	3,163	-12.8%	Shares	Sole	2023-10-31
2023-06-30	$1,701,928	3,629	+4.9%	Shares	Sole	2023-07-20
2023-03-31	$1,187,889	3,459	+21.2%	Shares	Sole	2023-04-19
2022-12-31	$1,044,107	2,854	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.